The list of CBD and cannabinoid-based wellness supplement pure-play stocks isn’t nearly as long as it used to be – which is good for bulls in the space going forward. That’s an enormous facet of “cyclicality” in markets – supply destruction. In this case, we are talking about destruction in the supply of shares of stocks purporting to be serious players in the space.
No one doubts the long-term growth potential for the cannabinoid-based product space. But we have seen such dramatic forecasts from analysts and researchers that we have been forced to endure a parade of pretenders before the wheat could be separated from the chaff this year.
Again, this is all to the good for new prospective investors in the space.
You may not have heard of Tauriga Sciences Inc (OTCMKTS:TAUG) before, but we are betting you will be hearing a whole lot about the company going forward given some of its recent accomplishments and its overall vision, so we thought it would be a good idea to do some birds-eye-view research on the company and present our sense.
First off, this is a unique technology play. It’s not just a company with some hemp seeds and yet another logo to put on a bottle of CBD oil on backwaterecommercesite.com. The company is “about” its unique method of infusing supplements in chewing gum.
According to the company’s most recent release – a shareholder letter that gives a great deal of perspective – the company has already developed a stable of products based on its unique methods:
“First off, we have created and developed a unique product line of the highest quality – based on an innovative product vision. Our Tauri-Gum™ product line is comprised of six distinct flavors (or versions) of our proprietary “Functional” Chewing Gum, which exists as a Cannabinoid supplement. Three of the Flavors are infused with Cannabidiol (“CBD”) – Mint, Blood Orange, and Pomegranate. Two of the Flavors are infused with Cannabigerol (“CBG”) – Peach-Lemon and Black Currant. And one flavor is infused with Vitamin C and Zinc – Pear Bellini (Immune Booster). In addition, we have also developed our popular “pectin based” CBD infused Gum Drop product… All of our products meet the highest standards for quality and distinction even among the most selective consumers: Kosher Certified, Vegan, Lab Tested (NO THC), NON-GMO, Natural Flavors, Allergen Free, Gluten Free, GMP Certified Manufacturer, 100% Made in the USA.”
In other words, Tauriga Sciences Inc (OTCMKTS:TAUG) has already fully developed six flavors of supplement-infused gum, including CBD, CBG, and Vitamin C and Zinc as supplements. And it has proof on top-tier quality standards.
So, this is not an early-stage R&D play that’s going to promise all sorts of wonderful future products that may exist some day in the future. This is a commercial-stage company that has already completed the R&D work and successfully developed a core set of strong products ready for distribution.
Does TAUG have something special to set it apart from competitors? You bet.
“From a scientific standpoint, the sublingual delivery system is highly effective, providing optimal bioavailability. The oral mucosa in the mouth provides a complete and effective channel, as a delivery system, for ANY TYPE of health and wellness Supplement(s), resulting in enhanced bioavailability – in direct comparison to topicals or digested edibles. We also believe that there is a solid future in developing proprietary chewing gum(s) as a means of providing customers with numerous types of Supplements.”
In other words, it turns out the chewing gum angle is really valuable as a delivery mechanism for something like CBD. But you can’t just walk into that model tomorrow if you haven’t spent the years and dollars developing it. So, there’s a barrier to competition and no one else out there seems to be playing the same hand of cards.
We would also point out that Tauriga Sciences Inc (OTCMKTS:TAUG) is just rounding the corner toward a massive expansion in its end-market access and its presence with distributors and consumers. This is very much a developing story that looks poised for big new announcements ahead.
For example, the company just announced last week that it has become a certified Supplier at a number of major supermarket chains, including Food Lion, Stop & Shop, Giant, Hannaford, Martin’s, and Peapod. According to that release, the company is operating through the SupplierOne Platform, which is used by more than 1,200 Buyers and 330 Buying Companies.
On the same morning, Tauriga announced its approval from Square Inc. (NYSE:SQ) to process multiple types of financial transactions. Within hours, the company then also announced that it has obtained approval from Tampa International Airport (Code: TPA) to become a Registered Supplier.
Now, it its most recent shareholder letter, we are told of more big news to come:
“Over the coming days and weeks, the Company will be launching a major new product offering – while simultaneously rolling out the existing products on a national level through a new broad-based distribution agreement. We expect to have more details to share in the near term.”
So, hello new products. And hello broad-based nationwide distribution for existing products. Both are huge announcements yet to come.
In addition, there’s more to this company than just CBD gum. This is a serious life-sciences name with studies underway toward more significant regulatory attention:
Exhibit A: “We are developing a Pharmaceutical Grade version of Tauri-Gum™, aimed at treating extreme nausea as a side effect of ongoing chemotherapy treatment. The Company filed its Provisional Patent during March 2020 and is working diligently towards progressing to a Phase II Clinical Trial.”
Exhibit B: “During April 2020, the Company entered into a Collaboration Agreement with Aegea Biotechnologies Inc. to “Develop a Rapid, Multiplexed Novel Coronavirus (COVID-19) Test Designed to Exhibit Superior Performance.” The Company has invested nearly $300,000 into this Collaboration Agreement (as of August 24, 2020) and continues to realize important progress towards the joint strategic endpoints.”
In other words, we can also anticipate development toward chemo treatment aids and rapid Covid testing.
There are very few companies in any industry that can match that level of active commercially relevant narrative development, much less the CBD space. At this point, Tauriga Sciences Inc (OTCMKTS:TAUG) is worth a look given its aggressive bearing and its potential to emerge as a technologically differentiated play in a true leadership position in a market space that is regularly forecast to reach $25B in size in the next few years.
This article is part of JournalTranscript.com Networks. Read the JournalTranscript.com Networks Disclaimer.
Published at Tue, 25 Aug 2020 03:21:07 +0000